Evidence map›Paper›PMID 41900131›Full record

ArticleMolecules (Basel, Switzerland)2026

Prediction of Bandgap and Key Feature Analysis of Lead-Free Double Perovskite Oxides Based on Deep Learning.

Beibei Wang, Juan Wang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Beibei WangXi'an Key Laboratory of Advanced Photo-Electronics Materials and Energy Conversion Device, School of Electronic Information, Xijing University, Xi'an 710123, China.
Juan WangXi'an Key Laboratory of Advanced Photo-Electronics Materials and Energy Conversion Device, School of Electronic Information, Xijing University, Xi'an 710123, China.ORCID 0000-0002-2085-3727

Funding

Shaanxi Association for Science and Technology Youth Talent Support Program 20230520the Innovation Capability Support Plan Project of Shaanxi Province 2024ZC-KJXX-020
6 · The paper itself

Abstract

Lead-free double perovskites possess the capabilities of wide bandgap control, excellent photoelectric performance, and environmental friendliness. They are an ideal alternative system for addressing the heavy metal toxicity of lead-based perovskites and promoting their large-scale application. Precise control of their bandgap is key to the green transformation of optoelectronic devices. Bandgap, as a key parameter determining the photoelectric properties of materials, has limitations in traditional experimental determination and DFT calculation methods, such as being time consuming, labour intensive, costly, and difficult to achieve high-throughput screening. Deep learning provides an efficient solution to this problem, but current research has issues such as a single-model architecture and poor interpretability, which cannot effectively support bandgap regulation. This study utilised 2367 valid datasets of lead-free double perovskites sourced from the Materials Project database and relevant literature. Following preprocessing steps, including MinMaxScaler normalisation and Pearson correlation coefficient screening, the dataset was divided into a ratio of 7:1:2. The bandgap prediction capabilities of four models-MLP, deep ensemble learning, PINN, and Transformer-were systematically compared, with feature importance analysed using the SHAP method. The results show that the MLP model performs the best in medium-scale, structured feature prediction. The R

Indexed as

bandgap predictiondeep learning algorithmfeature selectionlead-free double perovskite oxideSHAP explanation

Identifiers

PMID41900131
PMCPMC13028725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.